E1 ReplicatedPreliminaryPEM not requiredRCTPeer-reviewedReviewed
Standard · 3 min
Randomized controlled trial of Siberian ginseng for chronic fatigue.
Hartz, A J, Bentler, S, Noyes, R et al. · Psychological medicine · 2004 · DOI
Quick Summary
This study tested whether Siberian ginseng could reduce fatigue in people with chronic fatigue lasting at least 6 months. Ninety-six people took either Siberian ginseng or a placebo pill for 2 months. While both groups improved during the study, the ginseng did not work better than placebo overall, though it showed some promise in people with moderate (not severe) fatigue.
Why It Matters
This study addresses the common clinical scenario of patients with ME/CFS seeking herbal remedies when conventional treatments are ineffective. The findings suggest that while Siberian ginseng may warrant further investigation in specific patient subgroups, it should not be recommended as a general treatment for chronic fatigue based on current evidence.
Observed Findings
Fatigue substantially decreased in both placebo and Siberian ginseng groups during the 2-month study period.
No statistically significant difference in fatigue reduction was found between treatment groups in the full sample analysis.
In the subgroup with less severe fatigue at baseline, Siberian ginseng showed a statistically significant benefit over placebo (P=0.04).
In subjects with fatigue duration ≥5 years, Siberian ginseng showed marginal efficacy compared to placebo (P=0.09).
Twenty of 96 randomized subjects (21%) did not provide data at 2-month follow-up.
Inferred Conclusions
Siberian ginseng is not effective as a general treatment for chronic fatigue unselected by severity.
Fatigue severity and duration may modify treatment response to Siberian ginseng, with possible benefit in moderate rather than severe fatigue.
Further research targeting patients with specific fatigue phenotypes (moderate severity, longer duration) may be warranted.
Remaining Questions
Which specific patient characteristics (fatigue severity, duration, phenotype, baseline biomarkers) would best predict responsiveness to Siberian ginseng?
Is the improvement in both treatment groups due to placebo response, natural recovery, regression to the mean, or true pharmacological effect?
What This Study Does Not Prove
This study does not prove that Siberian ginseng is ineffective for all patients with chronic fatigue—subgroup findings suggest possible benefit in moderate fatigue cases, but these were not pre-specified and lack statistical adjustment. The study cannot establish whether the substantial improvement in both groups reflects true treatment effect, placebo response, natural recovery, or other factors. High attrition (20 subjects lost to follow-up) limits confidence in the 2-month findings.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.
What is the optimal dosing, duration, and formulation of Siberian ginseng, and do results differ across different ginseng preparations?
Does Siberian ginseng have efficacy in ME/CFS diagnosed by international consensus criteria versus the unexplained fatigue phenotype used in this study?